ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19

BACKGROUND: COVID‐19 is caused by the coronavirus SARS‐CoV‐2, which uses angiotensin‐converting enzyme 2 (ACE‐2) as a receptor for cellular entry. It is theorized that ACE inhibitors (ACE‐Is) or angiotensin receptor blockers (ARBs) may increase vulnerability to SARS‐CoV‐2 by upregulating ACE‐2 expre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Intern Med
Main Authors: Tetlow, S., Segiet‐Swiecicka, A., O’Sullivan, R., O’Halloran, S., Kalb, K., Brathwaite‐Shirley, C., Alger, L., Ankuli, A., Baig, M.S., Catmur, F., Chan, T., Dudley, D., Fisher, J., Iqbal, M.U., Puczynska, J., Wilkins, R., Bygate, R., Roberts, P.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753609/
https://ncbi.nlm.nih.gov/pubmed/33210357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joim.13202
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares